Loading…
Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene
Multiple endocrine neoplasia type 1 (MEN1) is an inherited syndrome characterized by development of multiple endocrine tumors in affected individuals. The gene responsible for the disease has been mapped to chromosome 11q13 by linkage analysis, but the gene itself has not yet been identified. We all...
Saved in:
Published in: | Cancer research (Chicago, Ill.) Ill.), 1997-03, Vol.57 (6), p.1039-1042 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 1042 |
container_issue | 6 |
container_start_page | 1039 |
container_title | Cancer research (Chicago, Ill.) |
container_volume | 57 |
creator | DEBELENKO, L. V EMMERT-BUCK, M. R BURNS, A. L SPIEGEL, A. M LIOTTA, L. A COLLINS, F. S MARX, S. J CHANDRASEKHARAPPA, S. C MANICKAM, P KESTER, M GURU, S. C DIFRANCO, E. M OLUFEMI, S.-E AGARWAL, S LUBENSKY, I. A ZHUANG, Z |
description | Multiple endocrine neoplasia type 1 (MEN1) is an inherited syndrome characterized by development of multiple endocrine tumors in affected individuals. The gene responsible for the disease has been mapped to chromosome 11q13 by linkage analysis, but the gene itself has not yet been identified. We allelotyped 33 affected individuals from an extensive MEN1 kindred using eight polymorphic markers located on chromosome 11q13, including two new markers (D11S4907 and D11S4908) that we derived and mapped to the SEA-D11S913 region. Analysis of affected individuals revealed two separate recombination events, providing new centromeric and telomeric boundaries for the MEN1 gene. The present data indicate the MEN1 gene is located between markers D11S1883 and D11S4907, an approximate 2 Mb region on chromosome 11q13. |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_78886698</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16442462</sourcerecordid><originalsourceid>FETCH-LOGICAL-h299t-c06f38e35724b5c063bda2c7e19edc1da74756007201bf58b86028fef2f924043</originalsourceid><addsrcrecordid>eNqFkE9LxDAUxIMo67r6EYQcRPRQSNL861GW1RVWvei5pO2LG0nT2rTCfnuDFq-e3gzzY3jMEVpSketMcS6O0ZIQojPBFTtFZzF-JCsoEQu0KIhUTMolgq3pfTceesAmGH-ILuIGrAsQscGtC641HrswwvCVhO0GPO4Bt5MfXe8BQ2i6ekg4DtD13kRn8E8bxTdPm2d6i98hwDk6scZHuJjvCr3db17X22z38vC4vttle1YUY1YTaXMNuVCMVyK5vGoMqxXQApqaNkZxJSQhihFaWaErLQnTFiyzBeOE5yt0_dvbD93nBHEsWxdr8N6k76ZYKq21lIX-F6SSc8YlS-DlDE5VC03ZD2mQ4VDOA6b8as5NrI23gwm1i38Yk5RowfJvq9l5Tw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16442462</pqid></control><display><type>article</type><title>Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene</title><source>Free E-Journal (出版社公開部分のみ)</source><creator>DEBELENKO, L. V ; EMMERT-BUCK, M. R ; BURNS, A. L ; SPIEGEL, A. M ; LIOTTA, L. A ; COLLINS, F. S ; MARX, S. J ; CHANDRASEKHARAPPA, S. C ; MANICKAM, P ; KESTER, M ; GURU, S. C ; DIFRANCO, E. M ; OLUFEMI, S.-E ; AGARWAL, S ; LUBENSKY, I. A ; ZHUANG, Z</creator><creatorcontrib>DEBELENKO, L. V ; EMMERT-BUCK, M. R ; BURNS, A. L ; SPIEGEL, A. M ; LIOTTA, L. A ; COLLINS, F. S ; MARX, S. J ; CHANDRASEKHARAPPA, S. C ; MANICKAM, P ; KESTER, M ; GURU, S. C ; DIFRANCO, E. M ; OLUFEMI, S.-E ; AGARWAL, S ; LUBENSKY, I. A ; ZHUANG, Z</creatorcontrib><description>Multiple endocrine neoplasia type 1 (MEN1) is an inherited syndrome characterized by development of multiple endocrine tumors in affected individuals. The gene responsible for the disease has been mapped to chromosome 11q13 by linkage analysis, but the gene itself has not yet been identified. We allelotyped 33 affected individuals from an extensive MEN1 kindred using eight polymorphic markers located on chromosome 11q13, including two new markers (D11S4907 and D11S4908) that we derived and mapped to the SEA-D11S913 region. Analysis of affected individuals revealed two separate recombination events, providing new centromeric and telomeric boundaries for the MEN1 gene. The present data indicate the MEN1 gene is located between markers D11S1883 and D11S4907, an approximate 2 Mb region on chromosome 11q13.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>PMID: 9067266</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Alleles ; Biological and medical sciences ; Chromosome Mapping ; Chromosomes, Human, Pair 11 - genetics ; DNA, Neoplasm - genetics ; Endocrinopathies ; Female ; General aspects. Associated endocrine diseases. Endocrine paraneoplasic syndromes ; Genetic Markers ; Haplotypes - genetics ; Humans ; Male ; Medical sciences ; Multiple Endocrine Neoplasia Type 1 - genetics ; Pedigree ; Polymorphism, Genetic ; Recombination, Genetic</subject><ispartof>Cancer research (Chicago, Ill.), 1997-03, Vol.57 (6), p.1039-1042</ispartof><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2610852$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9067266$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DEBELENKO, L. V</creatorcontrib><creatorcontrib>EMMERT-BUCK, M. R</creatorcontrib><creatorcontrib>BURNS, A. L</creatorcontrib><creatorcontrib>SPIEGEL, A. M</creatorcontrib><creatorcontrib>LIOTTA, L. A</creatorcontrib><creatorcontrib>COLLINS, F. S</creatorcontrib><creatorcontrib>MARX, S. J</creatorcontrib><creatorcontrib>CHANDRASEKHARAPPA, S. C</creatorcontrib><creatorcontrib>MANICKAM, P</creatorcontrib><creatorcontrib>KESTER, M</creatorcontrib><creatorcontrib>GURU, S. C</creatorcontrib><creatorcontrib>DIFRANCO, E. M</creatorcontrib><creatorcontrib>OLUFEMI, S.-E</creatorcontrib><creatorcontrib>AGARWAL, S</creatorcontrib><creatorcontrib>LUBENSKY, I. A</creatorcontrib><creatorcontrib>ZHUANG, Z</creatorcontrib><title>Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>Multiple endocrine neoplasia type 1 (MEN1) is an inherited syndrome characterized by development of multiple endocrine tumors in affected individuals. The gene responsible for the disease has been mapped to chromosome 11q13 by linkage analysis, but the gene itself has not yet been identified. We allelotyped 33 affected individuals from an extensive MEN1 kindred using eight polymorphic markers located on chromosome 11q13, including two new markers (D11S4907 and D11S4908) that we derived and mapped to the SEA-D11S913 region. Analysis of affected individuals revealed two separate recombination events, providing new centromeric and telomeric boundaries for the MEN1 gene. The present data indicate the MEN1 gene is located between markers D11S1883 and D11S4907, an approximate 2 Mb region on chromosome 11q13.</description><subject>Alleles</subject><subject>Biological and medical sciences</subject><subject>Chromosome Mapping</subject><subject>Chromosomes, Human, Pair 11 - genetics</subject><subject>DNA, Neoplasm - genetics</subject><subject>Endocrinopathies</subject><subject>Female</subject><subject>General aspects. Associated endocrine diseases. Endocrine paraneoplasic syndromes</subject><subject>Genetic Markers</subject><subject>Haplotypes - genetics</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Multiple Endocrine Neoplasia Type 1 - genetics</subject><subject>Pedigree</subject><subject>Polymorphism, Genetic</subject><subject>Recombination, Genetic</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNqFkE9LxDAUxIMo67r6EYQcRPRQSNL861GW1RVWvei5pO2LG0nT2rTCfnuDFq-e3gzzY3jMEVpSketMcS6O0ZIQojPBFTtFZzF-JCsoEQu0KIhUTMolgq3pfTceesAmGH-ILuIGrAsQscGtC641HrswwvCVhO0GPO4Bt5MfXe8BQ2i6ekg4DtD13kRn8E8bxTdPm2d6i98hwDk6scZHuJjvCr3db17X22z38vC4vttle1YUY1YTaXMNuVCMVyK5vGoMqxXQApqaNkZxJSQhihFaWaErLQnTFiyzBeOE5yt0_dvbD93nBHEsWxdr8N6k76ZYKq21lIX-F6SSc8YlS-DlDE5VC03ZD2mQ4VDOA6b8as5NrI23gwm1i38Yk5RowfJvq9l5Tw</recordid><startdate>19970315</startdate><enddate>19970315</enddate><creator>DEBELENKO, L. V</creator><creator>EMMERT-BUCK, M. R</creator><creator>BURNS, A. L</creator><creator>SPIEGEL, A. M</creator><creator>LIOTTA, L. A</creator><creator>COLLINS, F. S</creator><creator>MARX, S. J</creator><creator>CHANDRASEKHARAPPA, S. C</creator><creator>MANICKAM, P</creator><creator>KESTER, M</creator><creator>GURU, S. C</creator><creator>DIFRANCO, E. M</creator><creator>OLUFEMI, S.-E</creator><creator>AGARWAL, S</creator><creator>LUBENSKY, I. A</creator><creator>ZHUANG, Z</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>19970315</creationdate><title>Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene</title><author>DEBELENKO, L. V ; EMMERT-BUCK, M. R ; BURNS, A. L ; SPIEGEL, A. M ; LIOTTA, L. A ; COLLINS, F. S ; MARX, S. J ; CHANDRASEKHARAPPA, S. C ; MANICKAM, P ; KESTER, M ; GURU, S. C ; DIFRANCO, E. M ; OLUFEMI, S.-E ; AGARWAL, S ; LUBENSKY, I. A ; ZHUANG, Z</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h299t-c06f38e35724b5c063bda2c7e19edc1da74756007201bf58b86028fef2f924043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Alleles</topic><topic>Biological and medical sciences</topic><topic>Chromosome Mapping</topic><topic>Chromosomes, Human, Pair 11 - genetics</topic><topic>DNA, Neoplasm - genetics</topic><topic>Endocrinopathies</topic><topic>Female</topic><topic>General aspects. Associated endocrine diseases. Endocrine paraneoplasic syndromes</topic><topic>Genetic Markers</topic><topic>Haplotypes - genetics</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Multiple Endocrine Neoplasia Type 1 - genetics</topic><topic>Pedigree</topic><topic>Polymorphism, Genetic</topic><topic>Recombination, Genetic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DEBELENKO, L. V</creatorcontrib><creatorcontrib>EMMERT-BUCK, M. R</creatorcontrib><creatorcontrib>BURNS, A. L</creatorcontrib><creatorcontrib>SPIEGEL, A. M</creatorcontrib><creatorcontrib>LIOTTA, L. A</creatorcontrib><creatorcontrib>COLLINS, F. S</creatorcontrib><creatorcontrib>MARX, S. J</creatorcontrib><creatorcontrib>CHANDRASEKHARAPPA, S. C</creatorcontrib><creatorcontrib>MANICKAM, P</creatorcontrib><creatorcontrib>KESTER, M</creatorcontrib><creatorcontrib>GURU, S. C</creatorcontrib><creatorcontrib>DIFRANCO, E. M</creatorcontrib><creatorcontrib>OLUFEMI, S.-E</creatorcontrib><creatorcontrib>AGARWAL, S</creatorcontrib><creatorcontrib>LUBENSKY, I. A</creatorcontrib><creatorcontrib>ZHUANG, Z</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DEBELENKO, L. V</au><au>EMMERT-BUCK, M. R</au><au>BURNS, A. L</au><au>SPIEGEL, A. M</au><au>LIOTTA, L. A</au><au>COLLINS, F. S</au><au>MARX, S. J</au><au>CHANDRASEKHARAPPA, S. C</au><au>MANICKAM, P</au><au>KESTER, M</au><au>GURU, S. C</au><au>DIFRANCO, E. M</au><au>OLUFEMI, S.-E</au><au>AGARWAL, S</au><au>LUBENSKY, I. A</au><au>ZHUANG, Z</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>1997-03-15</date><risdate>1997</risdate><volume>57</volume><issue>6</issue><spage>1039</spage><epage>1042</epage><pages>1039-1042</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>Multiple endocrine neoplasia type 1 (MEN1) is an inherited syndrome characterized by development of multiple endocrine tumors in affected individuals. The gene responsible for the disease has been mapped to chromosome 11q13 by linkage analysis, but the gene itself has not yet been identified. We allelotyped 33 affected individuals from an extensive MEN1 kindred using eight polymorphic markers located on chromosome 11q13, including two new markers (D11S4907 and D11S4908) that we derived and mapped to the SEA-D11S913 region. Analysis of affected individuals revealed two separate recombination events, providing new centromeric and telomeric boundaries for the MEN1 gene. The present data indicate the MEN1 gene is located between markers D11S1883 and D11S4907, an approximate 2 Mb region on chromosome 11q13.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>9067266</pmid><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-5472 |
ispartof | Cancer research (Chicago, Ill.), 1997-03, Vol.57 (6), p.1039-1042 |
issn | 0008-5472 1538-7445 |
language | eng |
recordid | cdi_proquest_miscellaneous_78886698 |
source | Free E-Journal (出版社公開部分のみ) |
subjects | Alleles Biological and medical sciences Chromosome Mapping Chromosomes, Human, Pair 11 - genetics DNA, Neoplasm - genetics Endocrinopathies Female General aspects. Associated endocrine diseases. Endocrine paraneoplasic syndromes Genetic Markers Haplotypes - genetics Humans Male Medical sciences Multiple Endocrine Neoplasia Type 1 - genetics Pedigree Polymorphism, Genetic Recombination, Genetic |
title | Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T04%3A42%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Haplotype%20analysis%20defines%20a%20minimal%20interval%20for%20the%20multiple%20endocrine%20neoplasia%20type%201%20(MEN1)%20gene&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=DEBELENKO,%20L.%20V&rft.date=1997-03-15&rft.volume=57&rft.issue=6&rft.spage=1039&rft.epage=1042&rft.pages=1039-1042&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E16442462%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-h299t-c06f38e35724b5c063bda2c7e19edc1da74756007201bf58b86028fef2f924043%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16442462&rft_id=info:pmid/9067266&rfr_iscdi=true |